These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29457201)

  • 1. Validity of oral fluid test for Delta-9-tetrahydrocannabinol in drivers using the 2013 National Roadside Survey Data.
    Jin H; Williams SZ; Chihuri ST; Li G; Chen Q
    Inj Epidemiol; 2018 Feb; 5(1):3. PubMed ID: 29457201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marijuana use in U.S. teen drivers: a comparison of a road-side survey of reported use and fluid tests for tetrahydrocannabinol (THC).
    Pressley JC; Arora A; Sarmah R
    Inj Epidemiol; 2019; 6(Suppl 1):25. PubMed ID: 31333991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between oral fluid and blood THC concentration: A systematic review and discussion of policy implications.
    Robertson MB; Li A; Yuan Y; Jiang A; Gjerde H; Staples JA; Brubacher JR
    Accid Anal Prev; 2022 Aug; 173():106694. PubMed ID: 35640367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of delta 9-tetrahydrocannabinol (THC) measures obtained from oral fluid samples in traffic safety.
    Romano E; Moore C; Kelley-Baker T; Torres-Saavedra PA
    Traffic Inj Prev; 2019; 20(7):667-672. PubMed ID: 31356118
    [No Abstract]   [Full Text] [Related]  

  • 5. Marijuana use and driving in Washington State: Risk perceptions and behaviors before and after implementation of retail sales.
    Eichelberger AH
    Traffic Inj Prev; 2019; 20(1):23-29. PubMed ID: 30822133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drivers who tested positive for cannabis in oral fluid: a longitudinal analysis of administrative data for Spain between 2011 and 2016.
    Herrera-Gómez F; García-Mingo M; Colás M; González-Luque JC; Alvarez FJ
    BMJ Open; 2019 Aug; 9(8):e026648. PubMed ID: 31455697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of Delta9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Dräger DrugTest.
    Laloup M; Del Mar Ramirez Fernandez M; Wood M; De Boeck G; Maes V; Samyn N
    Forensic Sci Int; 2006 Sep; 161(2-3):175-9. PubMed ID: 16842950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between observed signs of impairment and THC concentration in oral fluid.
    Fierro I; González-Luque JC; Alvarez FJ
    Drug Alcohol Depend; 2014 Nov; 144():231-8. PubMed ID: 25287325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between self-report of cannabis use and toxicological detection of THC/THCCOOH in blood and THC in oral fluid in drivers in a roadside survey.
    Van der Linden T; Silverans P; Verstraete AG
    Drug Test Anal; 2014; 6(1-2):137-42. PubMed ID: 23939912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Driving under the influence of cannabis: pitfalls, validation, and quality control of a UPLC-MS/MS method for the quantification of tetrahydrocannabinol in oral fluid collected with StatSure, Quantisal, or Certus collector.
    Wille SM; Di Fazio V; Ramírez-Fernandez Mdel M; Kummer N; Samyn N
    Ther Drug Monit; 2013 Feb; 35(1):101-11. PubMed ID: 23318281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability of roadside oral fluid testing devices for ∆
    Scherer JN; Vasconcelos M; Dalanhol CS; Govoni B; Dos Santos BP; Borges GR; de Gouveia GC; Viola PP; Carlson RLR; Martins AF; Costa JL; Huestis MA; Pechansky F
    Drug Test Anal; 2024 Mar; ():. PubMed ID: 38440942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The failings of
    Arkell TR; Spindle TR; Kevin RC; Vandrey R; McGregor IS
    Traffic Inj Prev; 2021; 22(2):102-107. PubMed ID: 33544004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis use as a risk factor for causing motor vehicle crashes: a prospective study.
    Brubacher JR; Chan H; Erdelyi S; Macdonald S; Asbridge M; Mann RE; Eppler J; Lund A; MacPherson A; Martz W; Schreiber WE; Brant R; Purssell RA
    Addiction; 2019 Sep; 114(9):1616-1626. PubMed ID: 31106494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supported liquid extraction (SLE) for the analysis of methylamphetamine, methylenedioxymethylamphetamine and delta-9-tetrahydrocannabinol in oral fluid and blood of drivers.
    Rositano J; Harpas P; Kostakis C; Scott T
    Forensic Sci Int; 2016 Aug; 265():125-30. PubMed ID: 26878366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are blood and oral fluid Δ
    McCartney D; Arkell TR; Irwin C; Kevin RC; McGregor IS
    Neurosci Biobehav Rev; 2022 Mar; 134():104433. PubMed ID: 34767878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment.
    Ramaekers JG; Moeller MR; van Ruitenbeek P; Theunissen EL; Schneider E; Kauert G
    Drug Alcohol Depend; 2006 Nov; 85(2):114-22. PubMed ID: 16723194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Δ(9) -tetrahydrocannabinol detection using DrugWipe5S(®) screening and oral fluid quantification after Quantisal™ collection for roadside drug detection via a controlled study with chronic cannabis users.
    Wille SM; Di Fazio V; Toennes SW; van Wel JH; Ramaekers JG; Samyn N
    Drug Test Anal; 2015 Mar; 7(3):178-86. PubMed ID: 24753449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.
    Huestis MA; Cone EJ
    J Anal Toxicol; 2004 Sep; 28(6):394-9. PubMed ID: 15516285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.
    Ménétrey A; Augsburger M; Favrat B; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mangin P; Giroud C
    J Anal Toxicol; 2005; 29(5):327-38. PubMed ID: 16105257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Δ
    Arkell TR; Kevin RC; Stuart J; Lintzeris N; Haber PS; Ramaekers JG; McGregor IS
    Drug Test Anal; 2019 Oct; 11(10):1486-1497. PubMed ID: 31442003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.